184 related articles for article (PubMed ID: 27455819)
21. [Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
Beketov AS; Sidorenko SV; Pisarev VV; Komarov RM
Antibiot Khimioter; 2003; 48(3):34-41. PubMed ID: 12914120
[TBL] [Abstract][Full Text] [Related]
22. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
23. Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
Huang CT; Chen CH; Chen WC; Wang YT; Lai CC; Fu PK; Kuo LK; Chen CM; Fang WF; Tu CY; Ku SC
Int J Antimicrob Agents; 2022 Jan; 59(1):106491. PubMed ID: 34871744
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis.
Wu R; Wang X; Cui P; Chen W; Yang W; Lai Y
J Chemother; 2024 Apr; ():1-11. PubMed ID: 38644652
[TBL] [Abstract][Full Text] [Related]
25. The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Guclu E; Kaya G; Ogutlu A; Karabay O
J Chemother; 2020 May; 32(3):118-123. PubMed ID: 32096456
[TBL] [Abstract][Full Text] [Related]
26. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
[TBL] [Abstract][Full Text] [Related]
27. An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Bodey GP; Elting LS; Narro J; Koller C; O'Brien S; Estey E; Benjamin R
J Antimicrob Chemother; 1993 Jul; 32(1):141-52. PubMed ID: 8226405
[TBL] [Abstract][Full Text] [Related]
28. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
Fujii Y; Ayame H; Inoue H; Fujita N; Miyoshi K; Murano K; Hatao K; Yaga K; Kaku K; Kaneko T
Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
[TBL] [Abstract][Full Text] [Related]
29. [A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
Li J; Miao J; Hu W
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):680-2. PubMed ID: 8731830
[TBL] [Abstract][Full Text] [Related]
30. The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
Lai CC; Chen WC; Kuo LK; Wang YT; Fu PK; Ku SC; Fang WF; Chen CM; Tu CY; Cheng WC; Chen CH
Medicine (Baltimore); 2023 Jul; 102(28):e34284. PubMed ID: 37443505
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Winston DJ; Bartoni K; Bruckner DA; Schiller GJ; Territo MC
Clin Infect Dis; 1998 Mar; 26(3):576-83. PubMed ID: 9524826
[TBL] [Abstract][Full Text] [Related]
32. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
[TBL] [Abstract][Full Text] [Related]
33. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
Kawai Y; Ueda T; Iwasaki H; Nakamura T
Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
[TBL] [Abstract][Full Text] [Related]
34. [Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections].
Iakovlev VP; Blatun LA; Puchkova LS; Svetukhin AM
Antibiot Khimioter; 1994 Dec; 39(12):31-4. PubMed ID: 7733785
[TBL] [Abstract][Full Text] [Related]
35. Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
Sipahi OR; Arda B; Nazli-Zeka A; Pullukcu H; Tasbakan M; Yamazhan T; Ozkoren-Calik S; Sipahi H; Ulusoy S
Int J Clin Pract; 2014 Feb; 68(2):230-5. PubMed ID: 24372736
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Huang JJ; Zeng Q; Yu JL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
Greenberg RN; Cayavec P; Danko LS; Bowen K; Montazemi R; Kearney PA; Johnson SB; Strodel WE
J Antimicrob Chemother; 1994 Sep; 34(3):391-401. PubMed ID: 7829413
[TBL] [Abstract][Full Text] [Related]
38. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
Thamprajamchit S; Chetchotisakd P; Thinkhamrop B
J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.
Lan SH; Chang SP; Lai CC; Lu LC; Tang HJ
Medicine (Baltimore); 2020 Feb; 99(8):e19321. PubMed ID: 32080150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]